Christoph U. Correll

Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia

Cai‐Lan Hou, Yu‐Tao Xiang, Zhonglei Wang et al. · Schizophrenia Research · 2016 · 68 citations

Medicine, Psychiatry, Neuropsychiatry +11

Biological treatment of Acute Agitation Or Aggression with Schizophrenia Or Bipolar Disorder in the Inpatient Setting

Christoph U. Correll, Xin Yu, Yu‐Tao Xiang et al. · Annals of Clinical Psychiatry · 2017 · 56 citations

Medicine, Pharmacotherapy, Psychiatry +17

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China

Qian Li, Yu‐Tao Xiang, Yun‐Ai Su et al. · Australian & New Zealand Journal of Psychiatry · 2014 · 44 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Attention‐deficit/hyperactivity disorder (<scp>ADHD</scp>) in adults: evidence base, uncertainties and controversies

Samuele Cortese, Mark A. Bellgrove, Isabell Brikell et al. · World Psychiatry · 2025 · 33 citations · Full text

Medicine, Psychiatry, Psychology +17

An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

Cheng Zhang, Yanbo Yuan, Xue Han et al. · Journal of Psychopharmacology · 2019 · 32 citations

Pharmacy, Pharmacotherapy, Psychiatry +16